Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Derek Tang"'
Autor:
Valerie Hoerster, Derek Tang, Marlee Milkis, Stephanie Litzenberger, Jill Stoltzfus, Holly Stankewicz
Publikováno v:
Journal of Emergencies, Trauma and Shock, Vol 16, Iss 4, Pp 177-181 (2023)
Introduction: To date, there is limited literature to guide emergency providers (EPs) on the proper dosing of prescription opioids. Our study aims to assess the self-reported opioid use, storage, and disposal practices of patients presenting to the e
Externí odkaz:
https://doaj.org/article/5fdeb267325e4f199c14b5e593a54770
Autor:
John Mascarenhas, Krishnaveni Subbiah, Shalon Jones, Tao Gu, Derek Tang, Irene Degutis, Mrudula Glassberg
Publikováno v:
HemaSphere, Vol 7, p e926360f (2023)
Externí odkaz:
https://doaj.org/article/1075c5ed1e214767aef16a19450dfb76
Autor:
Shaloo Gupta, Austin G. Kulasekararaj, Halley Costantino, Jay Grisolano, Jackson Tang, Shalon Jones, Derek Tang
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background The current study investigated physicians' understanding of the impact of transfusion status (TS) on clinical and economic outcomes in patients with myelodysplastic syndromes (MDS). Materials & Methods 378 physicians primarily spe
Externí odkaz:
https://doaj.org/article/ff5ce9f874dc4723be4ecdf4932c869d
Autor:
Ruben A. Mesa, Nicolaas Schaap, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srdan Verstovsek, Shelonitda Rose, Pranav Abraham, Jennifer Lord-Bessen, Derek Tang, Shien Guo, Xiaomei Ye, Claire N. Harrison
Publikováno v:
HemaSphere, Vol 5, Iss 5, p e553 (2021)
Patients with myelofibrosis (MF) experience an array of symptoms that impair health-related quality of life (HRQoL). Fedratinib, an oral, selective Janus-kinase 2 (JAK2) inhibitor, was investigated in the randomized, placebo-controlled, phase III JAK
Externí odkaz:
https://doaj.org/article/628243f171b943f09d35b8a02bf0dbf2
Autor:
Claire N. Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Eric Jourdan, Richard T. Silver, Harry C. Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srdan Verstovsek, Derek Tang, Pranav Abraham, Jennifer Lord-Bessen, Shelonitda Rose, Shien Guo, Weiqin Liao, Ruben A. Mesa
Publikováno v:
HemaSphere, Vol 5, Iss 5, p e562 (2021)
Myelofibrosis symptoms compromise health-related quality of life (HRQoL). Ruxolitinib can reduce myelofibrosis symptom severity, but many patients discontinue ruxolitinib due to loss of response or unacceptable toxicity. Fedratinib is an oral, select
Externí odkaz:
https://doaj.org/article/6f0f1cefcf9e4277a2ace7bd18ecb259
Autor:
Esther Natalie Oliva, Krystal Huey, Sohan Deshpande, Monica Turner, Madhura Chitnis, Emma Schiller, Derek Tang, Aylin Yucel, Christina Hughes, Farrukh Shah
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 3, p 895 (2022)
Anemia is the most common form of cytopenia in patients with myelodysplastic syndromes (MDS), who require chronic red blood cell transfusions and may present high serum ferritin (SF) levels as a result of iron overload. To better understand the poten
Externí odkaz:
https://doaj.org/article/62483a1f57534801b2985395026ce78a
Autor:
Esther Natalie Oliva, Uwe Platzbecker, Guillermo Garcia-Manero, Ghulam J. Mufti, Valeria Santini, Mikkael A. Sekeres, Rami S. Komrokji, Jeevan K. Shetty, Derek Tang, Shien Guo, Weiqin Liao, George Zhang, Xianwei Ha, Rodrigo Ito, Jennifer Lord-Bessen, Jay T. Backstrom, Pierre Fenaux
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 1, p 27 (2021)
Patients with myelodysplastic syndromes (MDS) often experience chronic anemia and long-term red blood cell transfusion dependence associated with significant burden on clinical and health-related quality of life (HRQoL) outcomes. In the MEDALIST tria
Externí odkaz:
https://doaj.org/article/812658ba2be544528d997b5b0323d8bc
Autor:
Ulrich Germing, Pierre Fenaux, Uwe Platzbecker, Rena Buckstein, Valeria Santini, María Díez-Campelo, Aylin Yucel, Derek Tang, Shannon Fabre, George Zhang, Roberto Zoffoli, Xianwei Ha, Dimana Miteva, Christina Hughes, Rami S. Komrokji, Amer M. Zeidan, Guillermo Garcia-Manero
Publikováno v:
Annals of Hematology. 102:311-321
Red blood cell transfusion independence (RBC-TI) is an important goal in treating lower-risk myelodysplastic syndromes with ring sideroblasts. In the phase 3 MEDALIST study, RBC-TI of ≥ 8 weeks was achieved by significantly more luspatercept- versu
Autor:
Shaloo, Gupta, Austin G, Kulasekararaj, Halley, Costantino, Jay, Grisolano, Jackson, Tang, Shalon, Jones, Derek, Tang
Publikováno v:
Current Medical Research and Opinion. 39:239-247
Blood supply shortages may create unnecessary burden, including treatment delay, worsened quality of life, or increased healthcare resource utilization in patients with myelodysplastic syndromes (MDS). This study examined physicians' experience with
Autor:
Maria Domenica Cappellini, Ali T. Taher, Antonio Piga, Farrukh Shah, Ersi Voskaridou, Vip Viprakasit, John B. Porter, Olivier Hermine, Ellis J. Neufeld, Alexis A. Thompson, Derek Tang, Aylin Yucel, Jennifer Lord‐Bessen, Peiwen Yu, Shien Guo, Jeevan K. Shetty, Dimana Miteva, Tatiana Zinger, Jay T. Backstrom, Esther Natalie Oliva
Publikováno v:
European Journal of Haematology.